GROWWAMC - GROWWMOM50 (NSE: GROWWMOM50) is a listed company in the Mutual Fund Scheme industry. With a market capitalisation of ₹0 Cr, it ranks #5,369 by market cap among the 6,197 Indian listed companies on FinBizNet, and #46 of 115 in Mutual Fund Scheme. At ₹11.04 (as of 16 Nov 2026), the share price is 4.4% below its 52-week high of ₹11.55 and 21.1% above its 52-week low of ₹9.12. The share price is up 3.0% over one year and down 0.2% over three months.
| Current Price | ₹11.04 |
|---|---|
| Market Cap | ₹0 Cr |
| NSE Symbol | GROWWMOM50 |
| Sector | Financials > Financial Services > Capital Markets |
| Sub-Industry | Mutual Fund Scheme |
| 52-Week Range | ₹9.12 – ₹11.55 |
| 1-Year Price Change | +3.0% |
| 3-Month Price Change | -0.2% |
| Beta (1Y) | 0.4 |
| Website | groww.in/etfs/groww-nifty-momentum-etf |
Delivery averaged 59.2% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Groww Nifty 500 Momentum 50 ETF is headquartered in India.
1. NA-NA 2. NA-NA 3. NA-NA 4. NA-NA
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| EDELAMC - ENIFTY | ₹16 Cr | — | — | — | — |
| BANDHANAMC - SILVERBND | ₹10 Cr | — | — | — | — |
| GROWWAMC - GROWWCAPM | ₹8 Cr | — | — | — | — |
| KOTAKMAMC - CHEMICAL | ₹7 Cr | — | — | — | — |
| MOTILALAMC - MOMNC | ₹5 Cr | — | — | — | — |
| MOTILALAMC - MOPSE | ₹5 Cr | — | — | — | -1.7% |
| MOTILALAMC - MOTOUR | ₹5 Cr | — | — | — | -4.0% |
| GROWWAMC - GROWWMOM50 | ₹0 Cr | — | — | — | +3.0% |
| 360ONEAMC - GOLD360 | ₹0 Cr | — | — | — | +56.7% |
Listed by market capitalisation. Ratios are shown for context only.
GROWWAMC - GROWWMOM50 is trading at ₹11.04, with a market capitalisation of ₹0 Cr.
GROWWAMC - GROWWMOM50 operates in the Financials > Financial Services > Capital Markets space (Mutual Fund Scheme).
GROWWAMC - GROWWMOM50 is listed on the NSE under the symbol GROWWMOM50.
GROWWAMC - GROWWMOM50's share price is up 3.0% over one year and down 0.2% over three months. Its 52-week range is ₹9.12 to ₹11.55.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.